Feline lymphoma virus, also known as feline leukemia virus (FeLV), is a retrovirus that primarily affects domestic cats. It belongs to the family Retroviridae and the genus Gammaretrovirus. FeLV is a significant pathogen in the feline population, causing a range of clinical symptoms, including lymphoma, leukemia, and immunosuppression.
The virus is typically spread through close contact between infected and non-infected cats. It is present in various body fluids, such as saliva, urine, and milk, which can facilitate transmission. Kittens can also contract FeLV during gestation or through an infected mother's milk. Outdoor cats, sick or immunocompromised felines, and cats living in crowded environments are at a higher risk of contracting the virus.
FeLV infection can result in various outcomes. Some infected cats may exhibit no symptoms and become lifelong carriers, potentially transmitting the virus to other cats. Others may develop a range of health problems, including anemia, weight loss, fever, diarrhea, respiratory issues, and swollen lymph nodes. The most severe consequence of FeLV infection is the development of lymphoma, a type of cancer that affects the lymphatic system.
Diagnosis of feline lymphoma virus typically involves blood tests to detect the presence of viral antigens or antibodies. Treatment options for FeLV are limited, focusing mainly on supporting the cat's immune system and managing secondary infections. Preventive measures, such as vaccination, strict isolation of infected cats, and testing prior to introducing new cats into a household or breeding program, are crucial for controlling the spread of the virus.
Overall, feline lymphoma virus is a retrovirus that poses a significant risk to the feline population, leading to various health issues, including lymphoma
